NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.
NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.
复制标题
DOI:
10.1016/j.addr.2018.03.006
复制
发表时间:
2018-02-01
影响因子:
16.1
通讯作者:
Tseng HR
中科院分区:
文献类型:
--
作者:
Jan YJ;Chen JF;Zhu Y;Lu YT;Chen SH;Chung H;Smalley M;Huang YW;Dong J;Chen LC;Yu HH;Tomlinson JS;Hou S;Agopian VG;Posadas EM;Tseng HR
Circulating tumor cells (CTCs) are cancer cells shredded from either a primary tumor or a metastatic site and circulate in the blood as the potential cellular origin of metastasis. By detecting and analyzing CTCs, we will be able to noninvasively monitor disease progression in individual cancer patients and obtain insightful information for assessing disease status, thus realizing the concept of “tumor liquid biopsy”. However, it is technically challenging to identify CTCs in patient blood samples because of the extremely low abundance of CTCs among a large number of hematologic cells. In order to address this challenge, our research team at UCLA pioneered a unique concept of “NanoVelcro” cell-affinity substrates, in which CTC capture agent-coated nanostructured substrates were utilized to immobilize CTCs with remarkable efficiency. Four generations of NanoVelcro CTC assays have been developed over the past decade for a variety of clinical utilities. The 1st-gen NanoVelcro chips, composed of a silicon nanowire substrate (SiNS) and an overlaid microfluidic chaotic mixer, were created for CTC enumeration. The 2nd-gen NanoVelcro chips (i.e., NanoVelcro-LMD), based on polymer nanosubstrates, were developed for single-CTC isolation in conjunction with the use of the laser microdissection (LMD) technique. By grafting thermoresponsive polymer brushes onto SiNS, the 3rd-gen Thermoresponsive NanoVelcro chips have demonstrated the capture and release of CTCs at 37 and 4 °C respectively, thereby allowing for rapid CTC purification while maintaining cell viability and molecular integrity. Fabricated with boronic acid-grafted conducting polymer-based nanomaterial on chip surface, the 4th-gen NanoVelcro Chips (Sweet chip) were able to purify CTCs with well-preserved RNA transcripts, which could be used for downstream analysis of several cancer specific RNA biomarkers. In this review article, we will summarize the development of the four generations of NanoVelcro CTC Assays, and the clinical applications of each generation of devices.
登录
查看更多内容
影响因子:
158.5
作者:
Cristofanilli, M;Budd, GT;Hayes, DF
通讯作者:
Hayes, DF
影响因子:
6.1
作者:
Earhart CM;Hughes CE;Gaster RS;Ooi CC;Wilson RJ;Zhou LY;Humke EW;Xu L;Wong DJ;Willingham SB;Schwartz EJ;Weissman IL;Jeffrey SS;Neal JW;Rohatgi R;Wakelee HA;Wang SX
通讯作者:
Wang SX
DOI:
10.1073/pnas.0507904102
发表时间:
2005-11-08
影响因子:
11.1
作者:
Diehl, F;Li, M;Vogelstein, B
通讯作者:
Vogelstein, B
DOI:
10.1056/nejmoa1315815
发表时间:
2014-09-11
期刊:
The New England journal of medicine
影响因子:
--
作者:
Antonarakis ES;Lu C;Wang H;Luber B;Nakazawa M;Roeser JC;Chen Y;Mohammad TA;Chen Y;Fedor HL;Lotan TL;Zheng Q;De Marzo AM;Isaacs JT;Isaacs WB;Nadal R;Paller CJ;Denmeade SR;Carducci MA;Eisenberger MA;Luo J
通讯作者:
Luo J
影响因子:
3.4
作者:
Fend, F;Raffeld, M
通讯作者:
Raffeld, M